Dylan Hennessey
Overview
Explore the profile of Dylan Hennessey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gniadecki R, OKeefe S, Hennessey D, Iyer A
Cells
. 2023 Jun;
12(12).
PMID: 37371087
Ultraviolet (UV) radiation is a strong environmental carcinogen responsible for the pathogenesis of most skin cancers, including malignant melanoma (MM) and non-melanoma (keratinocyte) skin cancers. The carcinogenic role of UV...
2.
Gniadecki R, Iyer A, Hennessey D, Khan L, OKeefe S, Redmond D, et al.
J Autoimmun
. 2022 Jul;
131:102847.
PMID: 35803104
Objectives: Systemic sclerosis (SSc) is associated with secondary malignancies. Previous studies have suggested that mutated cancer proteins, such as RNA polymerase III, are autoantigens promoting an inflammatory response in SSc....
3.
Iyer A, Hennessey D, Gniadecki R
Blood Adv
. 2022 Jan;
6(7):2334-2345.
PMID: 35015812
Mature T-cell lymphomas (TCLs) are rare, clinically heterogeneous hematologic cancers with high medical need. TCLs have an inferior prognosis which is attributed to poor understanding of their pathogenesis. On the...
4.
Sivanand A, Hennessey D, Iyer A, OKeefe S, Surmanowicz P, Vaid G, et al.
Front Immunol
. 2020 Dec;
11:561234.
PMID: 33329522
Background: Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma, for which there is no cure. Immune checkpoint inhibitors have been tried in MF but the results have been...
5.
Iyer A, Hennessey D, OKeefe S, Patterson J, Wang W, Wong G, et al.
Sci Rep
. 2020 Sep;
10(1):15483.
PMID: 32968137
Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma. Lesions of MF are formed by hematogenous seeding the skin with polyclonal (clonotypically diverse) neoplastic T-cells which accumulate numerous mutations...
6.
Iyer A, Hennessey D, OKeefe S, Patterson J, Wang W, Wong G, et al.
Blood Adv
. 2020 Jun;
4(11):2489-2500.
PMID: 32502269
Mycosis fungoides (MF) is a slowly progressive cutaneous T-cell lymphoma (CTCL) for which there is no cure. In the early plaque stage, the disease is indolent, but development of tumors...
7.
Iyer A, Hennessey D, OKeefe S, Patterson J, Wang W, Wong G, et al.
Blood
. 2019 Sep;
134(18):1517-1527.
PMID: 31515249
Mycosis fungoides (MF) is a mature T-cell lymphoma currently thought to develop primarily in the skin by a clonal expansion of a transformed, resident memory T cell. However, this concept...
8.
Iyer A, Hennessey D, OKeefe S, Patterson J, Wang W, Salopek T, et al.
Blood Adv
. 2019 Apr;
3(7):1175-1184.
PMID: 30967393
Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, is believed to represent a clonal expansion of a transformed skin-resident memory T cell. T-cell receptor (TCR) clonality (ie,...